Chris Wiebe, BSc, BSC Med, MD, FRCPC
Dr. Wiebe has published on the clinical and pathologic risk factors for de novo donor-specific antibody development. He also has developed expertise in the quantification and identification of the HLA alloepitopes mismatched between donor and recipient HLA alleles and has published on the role these play as predictors of dnDSA development. Ongoing work investigates the potential for HLA molecular mismatch to serve as a predictive and prognostic biomarker in renal transplantation.
Dr. Wiebe is a transplant nephrologist and associate professor of internal medicine and immunology with expertise in immunogenetics and the development of de novo donor-specific antibodies in renal transplantation.
Visit Chris Wiebe's ResearchGate profile for a complete listing.